nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP2C9—Ifosfamide—testicular cancer	0.164	0.241	CbGbCtD
Rimonabant—CYP3A4—Ifosfamide—testicular cancer	0.0952	0.14	CbGbCtD
Rimonabant—CYP1A2—Etoposide—testicular cancer	0.0869	0.128	CbGbCtD
Rimonabant—CYP2C9—Cisplatin—testicular cancer	0.0797	0.117	CbGbCtD
Rimonabant—CYP2D6—Vinblastine—testicular cancer	0.0794	0.117	CbGbCtD
Rimonabant—CYP3A4—Vinblastine—testicular cancer	0.0505	0.0742	CbGbCtD
Rimonabant—CYP2D6—Doxorubicin—testicular cancer	0.0488	0.0717	CbGbCtD
Rimonabant—CYP3A4—Etoposide—testicular cancer	0.0455	0.0669	CbGbCtD
Rimonabant—CYP3A4—Doxorubicin—testicular cancer	0.031	0.0456	CbGbCtD
Rimonabant—Infestation NOS—Ifosfamide—testicular cancer	0.00215	0.00674	CcSEcCtD
Rimonabant—Infestation—Ifosfamide—testicular cancer	0.00215	0.00674	CcSEcCtD
Rimonabant—Infection—Chlorambucil—testicular cancer	0.00206	0.00646	CcSEcCtD
Rimonabant—Convulsion—Vinblastine—testicular cancer	0.00202	0.00632	CcSEcCtD
Rimonabant—Abdominal discomfort—Cisplatin—testicular cancer	0.00199	0.00625	CcSEcCtD
Rimonabant—Cramp muscle—Etoposide—testicular cancer	0.00199	0.00622	CcSEcCtD
Rimonabant—Anorexia—Chlorambucil—testicular cancer	0.00198	0.00619	CcSEcCtD
Rimonabant—Hallucination—Ifosfamide—testicular cancer	0.00192	0.00602	CcSEcCtD
Rimonabant—Connective tissue disorder—Ifosfamide—testicular cancer	0.0019	0.00595	CcSEcCtD
Rimonabant—Anorexia—Vinblastine—testicular cancer	0.00181	0.00568	CcSEcCtD
Rimonabant—Decreased appetite—Chlorambucil—testicular cancer	0.0018	0.00565	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00179	0.00561	CcSEcCtD
Rimonabant—Fatigue—Chlorambucil—testicular cancer	0.00179	0.0056	CcSEcCtD
Rimonabant—Angiopathy—Ifosfamide—testicular cancer	0.00175	0.00549	CcSEcCtD
Rimonabant—Mediastinal disorder—Ifosfamide—testicular cancer	0.00174	0.00545	CcSEcCtD
Rimonabant—Paraesthesia—Vinblastine—testicular cancer	0.00171	0.00535	CcSEcCtD
Rimonabant—Hiccups—Epirubicin—testicular cancer	0.0017	0.00533	CcSEcCtD
Rimonabant—Infestation NOS—Etoposide—testicular cancer	0.0017	0.00532	CcSEcCtD
Rimonabant—Infestation—Etoposide—testicular cancer	0.0017	0.00532	CcSEcCtD
Rimonabant—Gastrointestinal pain—Chlorambucil—testicular cancer	0.0017	0.00531	CcSEcCtD
Rimonabant—Mental disorder—Ifosfamide—testicular cancer	0.00169	0.0053	CcSEcCtD
Rimonabant—Malnutrition—Ifosfamide—testicular cancer	0.00168	0.00527	CcSEcCtD
Rimonabant—Decreased appetite—Vinblastine—testicular cancer	0.00165	0.00518	CcSEcCtD
Rimonabant—Abdominal pain—Chlorambucil—testicular cancer	0.00164	0.00514	CcSEcCtD
Rimonabant—Connective tissue disorder—Cisplatin—testicular cancer	0.00164	0.00513	CcSEcCtD
Rimonabant—Infection—Bleomycin—testicular cancer	0.00159	0.005	CcSEcCtD
Rimonabant—Hiccups—Doxorubicin—testicular cancer	0.00158	0.00494	CcSEcCtD
Rimonabant—Gastrointestinal pain—Vinblastine—testicular cancer	0.00155	0.00487	CcSEcCtD
Rimonabant—Anorexia—Bleomycin—testicular cancer	0.00153	0.00479	CcSEcCtD
Rimonabant—Hypoaesthesia—Etoposide—testicular cancer	0.00152	0.00475	CcSEcCtD
Rimonabant—Abdominal pain—Vinblastine—testicular cancer	0.0015	0.00471	CcSEcCtD
Rimonabant—Mediastinal disorder—Cisplatin—testicular cancer	0.0015	0.0047	CcSEcCtD
Rimonabant—Asthenia—Chlorambucil—testicular cancer	0.00149	0.00466	CcSEcCtD
Rimonabant—Infection—Dactinomycin—testicular cancer	0.00149	0.00466	CcSEcCtD
Rimonabant—Pruritus—Chlorambucil—testicular cancer	0.00147	0.0046	CcSEcCtD
Rimonabant—Convulsion—Ifosfamide—testicular cancer	0.00146	0.00456	CcSEcCtD
Rimonabant—Malnutrition—Cisplatin—testicular cancer	0.00145	0.00454	CcSEcCtD
Rimonabant—Paraesthesia—Bleomycin—testicular cancer	0.00144	0.00452	CcSEcCtD
Rimonabant—Anorexia—Dactinomycin—testicular cancer	0.00143	0.00447	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00142	0.00445	CcSEcCtD
Rimonabant—Diarrhoea—Chlorambucil—testicular cancer	0.00142	0.00445	CcSEcCtD
Rimonabant—Decreased appetite—Bleomycin—testicular cancer	0.0014	0.00437	CcSEcCtD
Rimonabant—Muscle spasms—Cisplatin—testicular cancer	0.00139	0.00437	CcSEcCtD
Rimonabant—Angiopathy—Etoposide—testicular cancer	0.00138	0.00434	CcSEcCtD
Rimonabant—Mediastinal disorder—Etoposide—testicular cancer	0.00137	0.00431	CcSEcCtD
Rimonabant—Asthenia—Vinblastine—testicular cancer	0.00136	0.00427	CcSEcCtD
Rimonabant—Infection—Ifosfamide—testicular cancer	0.00136	0.00427	CcSEcCtD
Rimonabant—Tremor—Cisplatin—testicular cancer	0.00136	0.00425	CcSEcCtD
Rimonabant—Lethargy—Methotrexate—testicular cancer	0.00135	0.00422	CcSEcCtD
Rimonabant—Nervous system disorder—Ifosfamide—testicular cancer	0.00135	0.00422	CcSEcCtD
Rimonabant—Skin disorder—Ifosfamide—testicular cancer	0.00133	0.00417	CcSEcCtD
Rimonabant—Hyperhidrosis—Ifosfamide—testicular cancer	0.00133	0.00416	CcSEcCtD
Rimonabant—Hot flush—Epirubicin—testicular cancer	0.00132	0.00414	CcSEcCtD
Rimonabant—Vomiting—Chlorambucil—testicular cancer	0.00132	0.00413	CcSEcCtD
Rimonabant—Menopausal symptoms—Epirubicin—testicular cancer	0.00131	0.0041	CcSEcCtD
Rimonabant—Anorexia—Ifosfamide—testicular cancer	0.00131	0.0041	CcSEcCtD
Rimonabant—Decreased appetite—Dactinomycin—testicular cancer	0.0013	0.00408	CcSEcCtD
Rimonabant—Diarrhoea—Vinblastine—testicular cancer	0.0013	0.00407	CcSEcCtD
Rimonabant—Fatigue—Dactinomycin—testicular cancer	0.00129	0.00404	CcSEcCtD
Rimonabant—Muscle spasms—Etoposide—testicular cancer	0.00128	0.004	CcSEcCtD
Rimonabant—Hypoglycaemia—Epirubicin—testicular cancer	0.00127	0.00397	CcSEcCtD
Rimonabant—Lethargy—Epirubicin—testicular cancer	0.00126	0.00395	CcSEcCtD
Rimonabant—Irritability—Methotrexate—testicular cancer	0.00126	0.00395	CcSEcCtD
Rimonabant—Dizziness—Vinblastine—testicular cancer	0.00126	0.00394	CcSEcCtD
Rimonabant—Convulsion—Cisplatin—testicular cancer	0.00126	0.00393	CcSEcCtD
Rimonabant—Mood swings—Methotrexate—testicular cancer	0.00125	0.00392	CcSEcCtD
Rimonabant—Nausea—Chlorambucil—testicular cancer	0.00123	0.00386	CcSEcCtD
Rimonabant—Paraesthesia—Ifosfamide—testicular cancer	0.00123	0.00386	CcSEcCtD
Rimonabant—Anxiety—Cisplatin—testicular cancer	0.00123	0.00385	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00123	0.00384	CcSEcCtD
Rimonabant—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00122	0.00384	CcSEcCtD
Rimonabant—Hot flush—Doxorubicin—testicular cancer	0.00122	0.00383	CcSEcCtD
Rimonabant—Menopausal symptoms—Doxorubicin—testicular cancer	0.00121	0.0038	CcSEcCtD
Rimonabant—Vomiting—Vinblastine—testicular cancer	0.00121	0.00379	CcSEcCtD
Rimonabant—Decreased appetite—Ifosfamide—testicular cancer	0.00119	0.00374	CcSEcCtD
Rimonabant—Headache—Vinblastine—testicular cancer	0.00119	0.00373	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00118	0.00371	CcSEcCtD
Rimonabant—Abdominal pain—Dactinomycin—testicular cancer	0.00118	0.00371	CcSEcCtD
Rimonabant—Fatigue—Ifosfamide—testicular cancer	0.00118	0.00371	CcSEcCtD
Rimonabant—Infection—Cisplatin—testicular cancer	0.00118	0.00368	CcSEcCtD
Rimonabant—Hypoglycaemia—Doxorubicin—testicular cancer	0.00117	0.00367	CcSEcCtD
Rimonabant—Mood swings—Epirubicin—testicular cancer	0.00117	0.00367	CcSEcCtD
Rimonabant—Lethargy—Doxorubicin—testicular cancer	0.00117	0.00366	CcSEcCtD
Rimonabant—Nervous system disorder—Cisplatin—testicular cancer	0.00116	0.00363	CcSEcCtD
Rimonabant—Asthenia—Bleomycin—testicular cancer	0.00115	0.00361	CcSEcCtD
Rimonabant—Convulsion—Etoposide—testicular cancer	0.00115	0.0036	CcSEcCtD
Rimonabant—Skin disorder—Cisplatin—testicular cancer	0.00115	0.0036	CcSEcCtD
Rimonabant—Hyperhidrosis—Cisplatin—testicular cancer	0.00114	0.00358	CcSEcCtD
Rimonabant—Pruritus—Bleomycin—testicular cancer	0.00114	0.00356	CcSEcCtD
Rimonabant—Nausea—Vinblastine—testicular cancer	0.00113	0.00354	CcSEcCtD
Rimonabant—Anorexia—Cisplatin—testicular cancer	0.00113	0.00353	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00112	0.00352	CcSEcCtD
Rimonabant—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00112	0.00351	CcSEcCtD
Rimonabant—Abdominal discomfort—Methotrexate—testicular cancer	0.00109	0.00343	CcSEcCtD
Rimonabant—Abdominal pain—Ifosfamide—testicular cancer	0.00108	0.0034	CcSEcCtD
Rimonabant—Mood swings—Doxorubicin—testicular cancer	0.00108	0.00339	CcSEcCtD
Rimonabant—Infection—Etoposide—testicular cancer	0.00108	0.00337	CcSEcCtD
Rimonabant—Asthenia—Dactinomycin—testicular cancer	0.00107	0.00337	CcSEcCtD
Rimonabant—Influenza—Epirubicin—testicular cancer	0.00107	0.00335	CcSEcCtD
Rimonabant—Paraesthesia—Cisplatin—testicular cancer	0.00106	0.00333	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00106	0.00332	CcSEcCtD
Rimonabant—Skin disorder—Etoposide—testicular cancer	0.00105	0.0033	CcSEcCtD
Rimonabant—Hyperhidrosis—Etoposide—testicular cancer	0.00105	0.00328	CcSEcCtD
Rimonabant—Anorexia—Etoposide—testicular cancer	0.00103	0.00324	CcSEcCtD
Rimonabant—Decreased appetite—Cisplatin—testicular cancer	0.00103	0.00322	CcSEcCtD
Rimonabant—Diarrhoea—Dactinomycin—testicular cancer	0.00102	0.00321	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00102	0.0032	CcSEcCtD
Rimonabant—Vomiting—Bleomycin—testicular cancer	0.00102	0.0032	CcSEcCtD
Rimonabant—Infestation NOS—Methotrexate—testicular cancer	0.00102	0.00319	CcSEcCtD
Rimonabant—Infestation—Methotrexate—testicular cancer	0.00102	0.00319	CcSEcCtD
Rimonabant—Depression—Methotrexate—testicular cancer	0.00101	0.00318	CcSEcCtD
Rimonabant—Rash—Bleomycin—testicular cancer	0.00101	0.00317	CcSEcCtD
Rimonabant—Dermatitis—Bleomycin—testicular cancer	0.00101	0.00317	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000993	0.00311	CcSEcCtD
Rimonabant—Influenza—Doxorubicin—testicular cancer	0.000988	0.0031	CcSEcCtD
Rimonabant—Asthenia—Ifosfamide—testicular cancer	0.000984	0.00308	CcSEcCtD
Rimonabant—Paraesthesia—Etoposide—testicular cancer	0.000973	0.00305	CcSEcCtD
Rimonabant—Pruritus—Ifosfamide—testicular cancer	0.000971	0.00304	CcSEcCtD
Rimonabant—Nausea—Bleomycin—testicular cancer	0.000954	0.00299	CcSEcCtD
Rimonabant—Infestation NOS—Epirubicin—testicular cancer	0.000952	0.00298	CcSEcCtD
Rimonabant—Infestation—Epirubicin—testicular cancer	0.000952	0.00298	CcSEcCtD
Rimonabant—Vomiting—Dactinomycin—testicular cancer	0.000952	0.00298	CcSEcCtD
Rimonabant—Rash—Dactinomycin—testicular cancer	0.000944	0.00296	CcSEcCtD
Rimonabant—Decreased appetite—Etoposide—testicular cancer	0.000942	0.00295	CcSEcCtD
Rimonabant—Diarrhoea—Ifosfamide—testicular cancer	0.000939	0.00294	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Etoposide—testicular cancer	0.000936	0.00293	CcSEcCtD
Rimonabant—Fatigue—Etoposide—testicular cancer	0.000934	0.00293	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000919	0.00288	CcSEcCtD
Rimonabant—Dizziness—Ifosfamide—testicular cancer	0.000907	0.00284	CcSEcCtD
Rimonabant—Sinusitis—Epirubicin—testicular cancer	0.000894	0.0028	CcSEcCtD
Rimonabant—Nausea—Dactinomycin—testicular cancer	0.000889	0.00279	CcSEcCtD
Rimonabant—Gastrointestinal pain—Etoposide—testicular cancer	0.000886	0.00278	CcSEcCtD
Rimonabant—Infestation NOS—Doxorubicin—testicular cancer	0.000881	0.00276	CcSEcCtD
Rimonabant—Infestation—Doxorubicin—testicular cancer	0.000881	0.00276	CcSEcCtD
Rimonabant—Vomiting—Ifosfamide—testicular cancer	0.000872	0.00273	CcSEcCtD
Rimonabant—Rash—Ifosfamide—testicular cancer	0.000865	0.00271	CcSEcCtD
Rimonabant—Dermatitis—Ifosfamide—testicular cancer	0.000864	0.00271	CcSEcCtD
Rimonabant—Abdominal pain—Etoposide—testicular cancer	0.000857	0.00268	CcSEcCtD
Rimonabant—Hypoaesthesia—Epirubicin—testicular cancer	0.000851	0.00266	CcSEcCtD
Rimonabant—Asthenia—Cisplatin—testicular cancer	0.000849	0.00266	CcSEcCtD
Rimonabant—Connective tissue disorder—Epirubicin—testicular cancer	0.00084	0.00263	CcSEcCtD
Rimonabant—Angiopathy—Methotrexate—testicular cancer	0.000829	0.0026	CcSEcCtD
Rimonabant—Sinusitis—Doxorubicin—testicular cancer	0.000827	0.00259	CcSEcCtD
Rimonabant—Mediastinal disorder—Methotrexate—testicular cancer	0.000823	0.00258	CcSEcCtD
Rimonabant—Nausea—Ifosfamide—testicular cancer	0.000815	0.00255	CcSEcCtD
Rimonabant—Diarrhoea—Cisplatin—testicular cancer	0.000809	0.00254	CcSEcCtD
Rimonabant—Mental disorder—Methotrexate—testicular cancer	0.0008	0.00251	CcSEcCtD
Rimonabant—Malnutrition—Methotrexate—testicular cancer	0.000795	0.00249	CcSEcCtD
Rimonabant—Hypoaesthesia—Doxorubicin—testicular cancer	0.000787	0.00247	CcSEcCtD
Rimonabant—Asthenia—Etoposide—testicular cancer	0.000777	0.00244	CcSEcCtD
Rimonabant—Connective tissue disorder—Doxorubicin—testicular cancer	0.000777	0.00244	CcSEcCtD
Rimonabant—Angiopathy—Epirubicin—testicular cancer	0.000776	0.00243	CcSEcCtD
Rimonabant—Mediastinal disorder—Epirubicin—testicular cancer	0.000771	0.00241	CcSEcCtD
Rimonabant—Pruritus—Etoposide—testicular cancer	0.000767	0.0024	CcSEcCtD
Rimonabant—Vomiting—Cisplatin—testicular cancer	0.000752	0.00236	CcSEcCtD
Rimonabant—Mental disorder—Epirubicin—testicular cancer	0.000749	0.00235	CcSEcCtD
Rimonabant—Rash—Cisplatin—testicular cancer	0.000746	0.00234	CcSEcCtD
Rimonabant—Dermatitis—Cisplatin—testicular cancer	0.000745	0.00233	CcSEcCtD
Rimonabant—Malnutrition—Epirubicin—testicular cancer	0.000744	0.00233	CcSEcCtD
Rimonabant—Diarrhoea—Etoposide—testicular cancer	0.000741	0.00232	CcSEcCtD
Rimonabant—Tension—Epirubicin—testicular cancer	0.00073	0.00229	CcSEcCtD
Rimonabant—Nervousness—Epirubicin—testicular cancer	0.000723	0.00226	CcSEcCtD
Rimonabant—Angiopathy—Doxorubicin—testicular cancer	0.000718	0.00225	CcSEcCtD
Rimonabant—Dizziness—Etoposide—testicular cancer	0.000717	0.00224	CcSEcCtD
Rimonabant—Muscle spasms—Epirubicin—testicular cancer	0.000716	0.00224	CcSEcCtD
Rimonabant—Mediastinal disorder—Doxorubicin—testicular cancer	0.000713	0.00223	CcSEcCtD
Rimonabant—Nausea—Cisplatin—testicular cancer	0.000703	0.0022	CcSEcCtD
Rimonabant—Mental disorder—Doxorubicin—testicular cancer	0.000693	0.00217	CcSEcCtD
Rimonabant—Convulsion—Methotrexate—testicular cancer	0.000689	0.00216	CcSEcCtD
Rimonabant—Vomiting—Etoposide—testicular cancer	0.000689	0.00216	CcSEcCtD
Rimonabant—Malnutrition—Doxorubicin—testicular cancer	0.000689	0.00216	CcSEcCtD
Rimonabant—Rash—Etoposide—testicular cancer	0.000683	0.00214	CcSEcCtD
Rimonabant—Dermatitis—Etoposide—testicular cancer	0.000683	0.00214	CcSEcCtD
Rimonabant—Headache—Etoposide—testicular cancer	0.000679	0.00213	CcSEcCtD
Rimonabant—Tension—Doxorubicin—testicular cancer	0.000676	0.00212	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000672	0.00211	CcSEcCtD
Rimonabant—Nervousness—Doxorubicin—testicular cancer	0.000669	0.0021	CcSEcCtD
Rimonabant—Muscle spasms—Doxorubicin—testicular cancer	0.000662	0.00207	CcSEcCtD
Rimonabant—Convulsion—Epirubicin—testicular cancer	0.000645	0.00202	CcSEcCtD
Rimonabant—Infection—Methotrexate—testicular cancer	0.000645	0.00202	CcSEcCtD
Rimonabant—Nausea—Etoposide—testicular cancer	0.000644	0.00202	CcSEcCtD
Rimonabant—Nervous system disorder—Methotrexate—testicular cancer	0.000637	0.00199	CcSEcCtD
Rimonabant—Anxiety—Epirubicin—testicular cancer	0.000631	0.00198	CcSEcCtD
Rimonabant—Skin disorder—Methotrexate—testicular cancer	0.00063	0.00198	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000629	0.00197	CcSEcCtD
Rimonabant—Hyperhidrosis—Methotrexate—testicular cancer	0.000627	0.00197	CcSEcCtD
Rimonabant—Dry mouth—Epirubicin—testicular cancer	0.00062	0.00194	CcSEcCtD
Rimonabant—Anorexia—Methotrexate—testicular cancer	0.000619	0.00194	CcSEcCtD
Rimonabant—Infection—Epirubicin—testicular cancer	0.000603	0.00189	CcSEcCtD
Rimonabant—Convulsion—Doxorubicin—testicular cancer	0.000597	0.00187	CcSEcCtD
Rimonabant—Nervous system disorder—Epirubicin—testicular cancer	0.000596	0.00187	CcSEcCtD
Rimonabant—Skin disorder—Epirubicin—testicular cancer	0.00059	0.00185	CcSEcCtD
Rimonabant—Hyperhidrosis—Epirubicin—testicular cancer	0.000587	0.00184	CcSEcCtD
Rimonabant—Insomnia—Methotrexate—testicular cancer	0.000587	0.00184	CcSEcCtD
Rimonabant—Anxiety—Doxorubicin—testicular cancer	0.000584	0.00183	CcSEcCtD
Rimonabant—Paraesthesia—Methotrexate—testicular cancer	0.000583	0.00183	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000582	0.00182	CcSEcCtD
Rimonabant—Anorexia—Epirubicin—testicular cancer	0.000579	0.00181	CcSEcCtD
Rimonabant—Dry mouth—Doxorubicin—testicular cancer	0.000573	0.0018	CcSEcCtD
Rimonabant—Decreased appetite—Methotrexate—testicular cancer	0.000564	0.00177	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00056	0.00176	CcSEcCtD
Rimonabant—Fatigue—Methotrexate—testicular cancer	0.00056	0.00175	CcSEcCtD
Rimonabant—Infection—Doxorubicin—testicular cancer	0.000558	0.00175	CcSEcCtD
Rimonabant—Nervous system disorder—Doxorubicin—testicular cancer	0.000551	0.00173	CcSEcCtD
Rimonabant—Insomnia—Epirubicin—testicular cancer	0.000549	0.00172	CcSEcCtD
Rimonabant—Skin disorder—Doxorubicin—testicular cancer	0.000546	0.00171	CcSEcCtD
Rimonabant—Paraesthesia—Epirubicin—testicular cancer	0.000545	0.00171	CcSEcCtD
Rimonabant—Hyperhidrosis—Doxorubicin—testicular cancer	0.000543	0.0017	CcSEcCtD
Rimonabant—Anorexia—Doxorubicin—testicular cancer	0.000536	0.00168	CcSEcCtD
Rimonabant—Gastrointestinal pain—Methotrexate—testicular cancer	0.000531	0.00166	CcSEcCtD
Rimonabant—Decreased appetite—Epirubicin—testicular cancer	0.000528	0.00165	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000524	0.00164	CcSEcCtD
Rimonabant—Fatigue—Epirubicin—testicular cancer	0.000524	0.00164	CcSEcCtD
Rimonabant—Abdominal pain—Methotrexate—testicular cancer	0.000513	0.00161	CcSEcCtD
Rimonabant—Insomnia—Doxorubicin—testicular cancer	0.000508	0.00159	CcSEcCtD
Rimonabant—Paraesthesia—Doxorubicin—testicular cancer	0.000505	0.00158	CcSEcCtD
Rimonabant—Gastrointestinal pain—Epirubicin—testicular cancer	0.000497	0.00156	CcSEcCtD
Rimonabant—Decreased appetite—Doxorubicin—testicular cancer	0.000489	0.00153	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000485	0.00152	CcSEcCtD
Rimonabant—Fatigue—Doxorubicin—testicular cancer	0.000485	0.00152	CcSEcCtD
Rimonabant—Abdominal pain—Epirubicin—testicular cancer	0.00048	0.0015	CcSEcCtD
Rimonabant—Asthenia—Methotrexate—testicular cancer	0.000466	0.00146	CcSEcCtD
Rimonabant—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00046	0.00144	CcSEcCtD
Rimonabant—Pruritus—Methotrexate—testicular cancer	0.000459	0.00144	CcSEcCtD
Rimonabant—Abdominal pain—Doxorubicin—testicular cancer	0.000444	0.00139	CcSEcCtD
Rimonabant—Diarrhoea—Methotrexate—testicular cancer	0.000444	0.00139	CcSEcCtD
Rimonabant—Asthenia—Epirubicin—testicular cancer	0.000436	0.00137	CcSEcCtD
Rimonabant—Pruritus—Epirubicin—testicular cancer	0.00043	0.00135	CcSEcCtD
Rimonabant—Dizziness—Methotrexate—testicular cancer	0.000429	0.00134	CcSEcCtD
Rimonabant—Diarrhoea—Epirubicin—testicular cancer	0.000416	0.0013	CcSEcCtD
Rimonabant—Vomiting—Methotrexate—testicular cancer	0.000413	0.00129	CcSEcCtD
Rimonabant—Rash—Methotrexate—testicular cancer	0.000409	0.00128	CcSEcCtD
Rimonabant—Dermatitis—Methotrexate—testicular cancer	0.000409	0.00128	CcSEcCtD
Rimonabant—Headache—Methotrexate—testicular cancer	0.000407	0.00127	CcSEcCtD
Rimonabant—Asthenia—Doxorubicin—testicular cancer	0.000403	0.00126	CcSEcCtD
Rimonabant—Dizziness—Epirubicin—testicular cancer	0.000402	0.00126	CcSEcCtD
Rimonabant—Pruritus—Doxorubicin—testicular cancer	0.000398	0.00125	CcSEcCtD
Rimonabant—Vomiting—Epirubicin—testicular cancer	0.000386	0.00121	CcSEcCtD
Rimonabant—Nausea—Methotrexate—testicular cancer	0.000386	0.00121	CcSEcCtD
Rimonabant—Diarrhoea—Doxorubicin—testicular cancer	0.000385	0.0012	CcSEcCtD
Rimonabant—Rash—Epirubicin—testicular cancer	0.000383	0.0012	CcSEcCtD
Rimonabant—Dermatitis—Epirubicin—testicular cancer	0.000383	0.0012	CcSEcCtD
Rimonabant—Headache—Epirubicin—testicular cancer	0.000381	0.00119	CcSEcCtD
Rimonabant—Dizziness—Doxorubicin—testicular cancer	0.000372	0.00116	CcSEcCtD
Rimonabant—Nausea—Epirubicin—testicular cancer	0.000361	0.00113	CcSEcCtD
Rimonabant—Vomiting—Doxorubicin—testicular cancer	0.000357	0.00112	CcSEcCtD
Rimonabant—Rash—Doxorubicin—testicular cancer	0.000354	0.00111	CcSEcCtD
Rimonabant—Dermatitis—Doxorubicin—testicular cancer	0.000354	0.00111	CcSEcCtD
Rimonabant—Headache—Doxorubicin—testicular cancer	0.000352	0.0011	CcSEcCtD
Rimonabant—Nausea—Doxorubicin—testicular cancer	0.000334	0.00105	CcSEcCtD
